Oncology Innovation: How Emerging Biotechs Lead Through RWD & AI

In an evolving biotech landscape, emerging companies are harnessing the power of real-world data (RWD) and artificial intelligence (AI) to help accelerate oncology drug development. This presentation explores how these cutting-edge tools help biotechs streamline clinical trials, optimize patient selection, and improve decision-making, even amidst challenging market conditions. Join us to discover how biotechs are leading the next wave of oncology innovation by leveraging advanced data strategies to bring therapies to patients faster and more effectively.